PlainPharmaWatch

CMS Open Payments · Program Year 2024

Actelion Pharmaceuticals US, Inc.

Actelion Pharmaceuticals US, Inc. reported $5,166,141.64 in payments to 31,311 physicians and teaching hospitals across 31,315 transactions.

See the rankings → How this is sourced
$5.2M
Total payments
31,315
Transactions
31,311
Recipients
+$101.9K
General Payments vs PY2023

Actelion Pharmaceuticals US, Inc. reported $5,166,141.64 in payments to 31,311 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #268 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $164.99 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Actelion Pharmaceuticals US, Inc. pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#268
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Actelion Pharmaceuticals US, Inc.'s CMS-reported General Payments increased by $101.9K (+2.1%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ACTELION PHARMACEUTICALS US, INC.PY2023: ACTELION PHARMACEUTICALS US, INC.PY2024: Actelion Pharmaceuticals US, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$4.9MPY2024$5.0M
PY2023
$4,902,789.78
PY2024
$5,004,722.78

How Actelion Pharmaceuticals US, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Actelion Pharmaceuticals US, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$5,166,142 Top 14% higher than 86% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Actelion Pharmaceuticals US, Inc.

Averaging $164.97 per transaction and $164.99 per recipient, Actelion Pharmaceuticals US, Inc.'s Program Year 2024 total comes to $5,166,141.64 across 31,315 transactions and 31,311 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #268 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 7 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $2.4M across 816 transactions, 45.9% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads Actelion Pharmaceuticals US, Inc.'s 7-category general-payment breakdown at $2.4M, 45.9% of the reported total.

How Actelion Pharmaceuticals US, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$2.4M2. Food and Beverage$898.2K3. Consulting Fee$733.2K4. Grant$420.0K5. Travel and Lodging$385.6K6. Space Rental or Facility …$106.6K7. Education$88.8K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $2.4M 816
Food and Beverage $898.2K 27,893
Consulting Fee $733.2K 211
Grant $420.0K 4
Travel and Lodging $385.6K 1,311
Space Rental or Facility Fees $106.6K 32
Education $88.8K 1,044

Recipient Concentration in General Payments

The five largest recipient relationships account for $803,201.96 (16.0%) of $5,004,722.78 in this company's General Payments records across 11,628 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Actelion Pharmaceuticals US, Inc.

The five named recipients with the highest reported General Payments from this company

Temple University Hospital$355.0KJohn Joseph Ryan$129.0KHunter C Champion$112.9KOmar a Minai$107.1KJohn W Mcconnell$99.3K
  1. 1

    Temple University Hospital

    $355,000.00 across 2 reported transactions

  2. 2

    John Joseph Ryan

    $128,960.24 across 137 reported transactions

  3. 3

    Hunter C Champion

    $112,856.96 across 104 reported transactions

  4. 4

    Omar a Minai

    $107,123.60 across 114 reported transactions

  5. 5

    John W Mcconnell

    $99,261.16 across 96 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $164.97. Average per recipient: $164.99.

Total Amount

$5,166,141.64

Avg per Transaction

$164.97

Avg per Recipient

$164.99

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Actelion Pharmaceuticals US, Inc. Share

0.0%

#268 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Actelion Pharmaceuticals US, Inc.

Intercept Pharmaceuticals, Inc.

$5.1M 13,236 recipients

SK Life Science, Inc.

$5.1M 20,538 recipients

Pristine Surgical LLC

$5.1M 5 recipients

BioXcel Therapeutics, Inc.

$5.2M 532 recipients

Mitsubishi Tanabe Pharma America, Inc.

$5.2M 3,683 recipients

BrainScope Company, Inc.

$5.1M 25 recipients

Frequently Asked Questions

How much did Actelion Pharmaceuticals US, Inc. pay to physicians and hospitals in 2024? ▾
Actelion Pharmaceuticals US, Inc. made $5,166,141.64 in payments to physicians and hospitals in Program Year 2024, across 31,315 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Actelion Pharmaceuticals US, Inc.? ▾
Actelion Pharmaceuticals US, Inc. made payments to 31,311 physicians and teaching hospitals in 2024. The average payment per recipient was $164.99.
What types of payments did Actelion Pharmaceuticals US, Inc. make? ▾
7 categories of general payment make up Actelion Pharmaceuticals US, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $2.4M, representing 45.9% of the company's reported total.
How does Actelion Pharmaceuticals US, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Actelion Pharmaceuticals US, Inc. sits at #268 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Actelion Pharmaceuticals US, Inc.? ▾
The average transaction from Actelion Pharmaceuticals US, Inc. was $164.97 in 2024. The company made 31,315 total transactions to 31,311 recipients.
Where does the payment data for Actelion Pharmaceuticals US, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Actelion Pharmaceuticals US, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.